Guangdong Biolight Meditech Co., Ltd. (SHE:300246)

SHE:300246 Revenue

Guangdong Biolight Meditech had revenue of 297.92M CNY in the quarter ending September 30, 2026, with 10.43% growth. This brings the company's total for the last twelve months to 1.12B, up 7.34% year-over-year. In the year 2025, Guangdong Biolight Meditech had annual revenue of 1.10B with 3.29% growth. That makes Guangdong Biolight Meditech the 18,773rd largest company in the world by revenue and 3,437th in China.

• Revenue (ttm): 1.12B
• Revenue Growth: +7.34%
• P/S Ratio: 3.15
• Revenue / Employee: 837.33K
• Employees: 1,335
• Market Cap: 3.52B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• industry 735.36M 69.3%
• Business 312.44M 29.5%
• Unallocated Other Operating Income 12.68M 1.2%

By Geography

Chart

• China 799.75M 75.4%
• Export 248.06M 23.4%
• Unallocated 12.68M 1.2%

Fiscal year ended Dec 31, 2024 See the full SHE:300246 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.10B	34.91M	3.29%
Dec 31, 2024	1.06B	-133.52M	-11.18%
Dec 31, 2023	1.19B	10.30M	0.87%
Jan 1, 2023	1.18B	92.68M	8.49%
Jan 1, 2022	1.09B	-305.00M	-21.85%

Data Source: S&P Global Market Intelligence Last updated: Oct 29, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 10, 2026

Data Sources Report a data error